- Home
- ECOR vs CATO Comparison
ECOR vs CATO Comparison
Compare ECOR & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ECOR | CATO |
|---|---|---|
| Founded | 2005 | 1946 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.4M | 59.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ECOR | CATO |
|---|---|---|
| Price | $6.26 | $3.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | ★ 71.4K | 64.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $28.92 | N/A |
| Revenue Next Year | $32.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.16 | $2.19 |
| 52 Week High | $19.49 | $4.92 |
Technical Indicators
Market Signals| Indicator | ECOR | CATO |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 45.45 |
| Support Level | $5.15 | $2.81 |
| Resistance Level | $6.89 | $3.15 |
| Average True Range (ATR) | 0.62 | 0.15 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 42.22 | 51.01 |
Price Performance
Historical ComparisonAbout ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.